PMV Pharmaceuticals, Inc
PMV Pharma develops small molecule therapies targeting p53 for oncology.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 10Latest story
November 2026
October 2026
September 2026
August 2026
PMV Pharma develops small molecule therapies targeting p53 for oncology.
November 2026
October 2026
September 2026
August 2026